BioSpace News Archive

Almelo, the Netherlands – Malvern Panalytical, a leading analytical instruments and services supplier, today launches a new version of its Aeris compact X-ray diffractometer (XRD).

Kit to be available for purchase at Walgreens without a prescription and will allow for greater access to testing, helping reduce the spread of COVID-19 and improve the health of communities

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that a supplemental New Drug Application (sNDA) has been submitted to the U.S. Food and Drug Administration (FDA) by ViiV Healthcare for the expanded use of CABENUVA (consisting of Janssen’s long-acting rilpivirine and ViiV Healthcare’s cabotegravir).

This is the first event of the 2021 Designing Our Future discussion series which convenes US and UK leaders in government, business and academia to tackle the world’s Grand Challenges.

Imricor Medical Systems, Inc. the global leader in MRI-guided cardiac ablation products, is pleased to announce the Maastricht University Medical Centre+ in the Netherlands has commenced procedures since the extended lockdowns across Europe precluded elective surgeries.

10x Genomics, Inc. detailed a slew of new products and announced the acquisition of Copenhagen-based Tetramer Shop at its inaugural Xperience 2021 event, a showcase with three breakout sessions corresponding to 10x’s three product platforms: Chromium Single Cell, Visium Spatial, and In Situ Analysis.

BridgeBio Pharma, Inc. announced that early results from an ongoing Phase 2 proof-of-concept study of encaleret for the treatment of Autosomal Dominant Hypocalcemia Type 1 will be shared at the upcoming Endocrine Society’s 2021 Annual Meeting taking place virtually from March 20 - 23.

Further established leadership in sickle cell disease (SCD) with data presentations on pipeline programs inclacumab and GBT021601 (GBT601)

Stereotaxis, the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced a 10-year CEO performance stock award for David Fischel with vesting entirely contingent upon the company achieving billion-dollar market capitalization milestones.

Merit Medical Systems, Inc., a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced revenue of $258.0 million for the quarter ended December 31, 2020, essentially flat compared to the prior year period.